Rapid Communications in Mass Spectrometry,
Год журнала:
2024,
Номер
38(20)
Опубликована: Авг. 26, 2024
Rationale
Nirmatrelvir
is
a
protease
inhibitor
that
essential
for
virus
replication.
indicated
the
management
of
mild
to
severe
cases
COVID‐19
in
individuals
who
are
12
years
age
or
older.
Forced
degradation
studies
nirmatrelvir
were
carried
out
on
drug
substance
solid
and
solution
forms,
subjecting
it
various
stress
conditions
according
International
Conference
Harmonisation
(ICH)
Q1A(R2)
Q1B
guidelines.
The
analytical
method
was
validated
as
per
ICH
Q2(R1)
Methods
(nirmatrelvir)
subjected
hydrolysis
(acidic,
alkaline,
neutral),
thermal,
photolytic,
oxidative
conditions.
Five
products
(DPs)
formed
under
hydrolytic
(acidic
alkaline)
(2,2‐azobisisobutyronitrile)
These
identified
separated
using
reverse‐phase
HPLC
phenomenex
kinetex
C8
column
(250
mm
×
4.6
5
μm)
with
gradient
elution.
mobile
phase
consisted
0.1%
formic
acid
acetonitrile,
detection
at
wavelength
210
nm.
Results
conclusions
its
five
DPs
efficiently
reverse
phase–HPLC.
characterized
LC‐electrospray
ionization
(ESI)‐Q‐TOF‐coupled
mass
spectrometry
analysis
ESI‐positive
mode.
formation
mechanisms
most
probable
fragmentation
pathways
both
elucidated.
developed
demonstrated
selectivity,
accuracy,
linearity,
reproducibility,
making
appropriate
quality
control
future
research
studies.
Additionally,
physicochemical
Absorption,
Distribution,
Metabolism,
Excretion,
Toxicity
(ADMET)
properties
predicted
ADMET
predictor
software.
toxicity
profile
revealed
DP2
DP3
have
teratogenic
effects
while
DP1
caused
phospholipidosis.
Carbohydrate Polymer Technologies and Applications,
Год журнала:
2024,
Номер
7, С. 100453 - 100453
Опубликована: Фев. 4, 2024
A
hybrid
of
microcrystalline
cellulose
(MCC)
with
metal
organic
frame
(MOF)
was
developed
as
an
efficient
adsorbent
for
dispersive
solid
phase
microextraction
(dSPME)
ritonavir
from
spiked
human
plasma.
The
sorbent
characterized
by
a
high-resolution
scanning
electron
microscope
(HR-SEM),
X-ray
diffraction
(XRD),
and
Fourier
transform
infrared
spectroscopy
(FTIR).
MCC
immersed
in
solution
CaCl2,
stirred
soda
water
1,3,5-benzenetricarboxylic
acid,
resulting
white
MCC/MOF
composites,
which
were
separated,
washed,
dried.
hybrids
examined
under
the
HR-SEM
showed
morphological
features
different
form
Ca-1,3,5-benzenetricarboxylic
acid
(Ca-BTC)
MOF.
patterns
Ca-BTC/MCC
composites
clearly
displayed
characteristic
Ca-BTC
MOF
bands,
indicating
that
successfully
incorporated
formation
crystalline
hybrids.
FTIR
spectra
exhibited
bands
MCC,
well
MOFs.
prepared
applied
dSPME
plasma,
before
determination
high
performance
liquid
chromatography
UV
detection.
After
method
optimization,
best
extraction
efficiency
achieved
using
12.50
mg
250
µL
acetonitrile
eluent.
This
novel
(Ca-BTC/MCC)
merges
advantages
surface
areas
MOFs
820
m2
g−1
biodegradability
sustainability
MCC.
Besides,
higher
compared
unmodified
To
our
knowledge,
this
work
applies
sorbents
first
time.
These
results
open
door
to
more
applications
these
sample
preparation
biomedical
analysis.
Heliyon,
Год журнала:
2025,
Номер
11(2), С. e41737 - e41737
Опубликована: Янв. 1, 2025
Currently,
the
trials
found
that
clinical
efficacy
of
molnupiravir
is
lower
than
ritonavir-boosted
nirmatrelvir.
An
explanation
for
these
different
efficacies
in
treatments
still
limited.
The
analysis
method
was
developed
and
validated
to
simultaneously
quantify
nirmatrelvir,
ritonavir,
beta-D-N4-hydroxycytidine
(NHC)
human
plasma
bronchoalveolar
lavage
fluid
(BALF)
by
electrospray
ionization
mass
spectrometry.
Our
over
a
linear
range
30-10000
ng/mL
both
matrices,
with
precision
accuracy
within
15
%
across
four
concentrations.
Recovery
rates
analytes
from
BALF
were
between
90.7-102.2
90.5-107.7
%,
respectively.
analytical
then
applied
monitor
therapeutic
drug
concentrations
59
samples
23
patients
receiving
nirmatrelvir
or
molnupiravir.
By
setting
target
292
1205
NHC,
based
on
vitro
antiviral
90
virus
inhibitory
(EC90),
drug's
molecular
weight
its
binding
proteins,
we
observed
had
substantially
greater
achieving
Additionally,
monitored
epithelial
lining
4
NHC
exhibited
higher
permeability
lung
tissue
(approximately
20
nirmatrelvir).
However,
subtherapeutic
also
present
fluid.
These
findings
highlight
importance
considering
factors
determining
drugs
treating
coronavirus
disease
2019
(COVID-19).
The
SARS-CoV-2
virus
sets
up
a
global
catastrophe,
and
countries
all
around
the
world
made
significant
efforts
to
halt
spread.
Nirmatrelvir
(NMV)
was
lately
approved
by
FDA
as
safe
well-tolerated
oral
direct-acting
antiviral
medication
for
infection.
Therefore,
fast
completely
validated
stability
indicating
method
established-for
first
time-
NMV
determination.
study
used
NaOH,
HCl,
neutral,
H2O2,
sunlight
test
under
various
stress
conditions
followed
kinetics
degradation
investigation
derivation
of
Arrhenius
plot.
analysis
performed
using
Agilent
Zorbax
Eclipse-C18
column
(5
µm,
4.6
×
250
mm)
with
mobile
phase
consisting
acetonitrile:
50
mM
ammonium
acetate,
pH
=
5
(50:50,
v/v,
respectively)
at
flow
rate
1.0
mL/min
min
run
time.
Diode
array
detector
(DAD)
set
225
nm
quantify
concentration
range
5-500
µg/mL
LOD
LOQ
0.6
2
µg/mL,
respectively.
Method's
greenness
assessed
different
metrics
including
Analytical
Eco-Scale,
Greenness
Assessment
Procedure
Index,
GAPI,
Greenness,
AGREE.
A
thorough
revealed
that
more
susceptible
alkaline
hydrolysis
compared
acid
hydrolysis.
In
contrast,
it
found
remained
stable
when
subjected
oxidative,
sun-induced
conditions.
Moreover,
alkali-induced
were
follow
pseudo
order
kinetics.
Consequently,
half
lifetime
studied
room
temperature
calculated
mechanism
pathways
circumstances
proposed
LC-MS-UV.
Toxicities
products
ProTox-II,
along
parent
NMV,
shown
be
hardly
hazardous.
Biomedical Chromatography,
Год журнала:
2024,
Номер
38(3)
Опубликована: Янв. 16, 2024
Abstract
A
systematic
and
novel
quality
by
design–enabled,
rapid,
simple,
economic
stability–indicating
HPLC
method
for
quantifying
nirmatrelvir
(NMT)
was
successfully
developed
validated.
An
analytical
target
profile
(ATP)
established,
critical
attributes
(CAAs)
were
allocated
to
meet
the
ATP
requirements.
The
used
chromatographic
separation
using
a
Purosphere
column
with
4.6
mm
inner
diameter
×
250
(2.5
μm).
analysis
occurred
at
50°C
flow
rate
of
1.2
mL/min
detection
220
nm.
10
μL
sample
injected,
mobile
phase
consisted
two
components:
A,
containing
0.1%
formic
acid
in
water
(20%),
B,
acetonitrile
(80%).
diluent
prepared
mixing
90:10
v/v
ratio.
retention
time
analyte
determined
be
2.78
min.
Accuracy
exceeded
99%,
correlation
coefficient
greater
than
0.999.
validated
characterized
as
precise,
accurate,
robust.
Significantly,
NMT
found
susceptible
alkaline,
acidic,
peroxide
conditions
during
forced
degradation
testing.
stability‐indicating
effectively
separated
products
formed
stress
testing,
underlining
its
effectiveness
stability
testing
offering
accuracy,
reliability,
sensitivity
determining
NMT.
RSC Advances,
Год журнала:
2023,
Номер
13(38), С. 26719 - 26731
Опубликована: Янв. 1, 2023
As
the
COVID-19
pandemic
is
not
yet
over,
Pfizer
has
launched
novel
pill
Paxlovid®
(Nirmatrelvir
(NMV)
co-packaged
with
ritonavir
(RIT))
as
an
effective
medication
for
hospitalized
and
non-hospitalized
patients.
Making
pharmaceutical
analysis
greener
more
sustainable
lately
become
main
direction
of
research
community.
In
this
context,
two
fast,
green,
stability-indicating
chromatographic
methods
were
designed
neat
quantitative
determination
NMV
RIT
in
their
bulk
dosage
forms.
Method
I
deemed
first
electro-driven
attempt
assay
Paxlovid®.
Herein,
optimized
conditions
Micellar
Electrokinetic
Chromatographic
(MEKC)
method
50
mM
borate
buffer
at
pH
9.2
25
sodium
lauryl
sulfate
(SDS)
being
used
background
electrolyte
(BGE)
on
a
deactivated
fused
silica
capillary
(50
cm
length
×
μm
id).
II
was
isocratic
reversed-phase
HPLC
separation
using
Zorbax-Eclipse
C18
(4.6
250
mm,
5
particle
size)
column
ammonium
acetate
acetonitrile
mobile
phase
constituents
flow
rate
1
mL
min-1.
For
sake
simplicity
increasing
sensitivity,
single
wavelength
210
nm
to
both
drugs.
Linear
correlations
between
peak
areas
concentration
observed
ranges
10-200
μg
mL-1
5-100
methods.
The
impact
versatile
stress
such
hydrolysis,
oxidation,
photolysis
stability
studied.
Fortunately,
methodologies
able
separate
drugs
from
degradants.
Thus,
indicating
power
proved.
derived
statistically
validated
agreement
ICH
guidelines.
Furthermore,
environmental
friendliness
sustainability
these
investigated
compared
cited
holistic
multicriteria
evaluation
tools
namely
Hexagon,
AGREE,
RGB12
metrics.
Conclusively,
proposed
offered
reliable,
feasible,
economic,
white,
alternatives
European Journal of Pharmaceutical Sciences,
Год журнала:
2023,
Номер
189, С. 106535 - 106535
Опубликована: Июль 23, 2023
Nirmatrelvir
is
an
effective
component
of
Paxlovid,
the
first
oral
antiviral
drug
granted
emergency
use
authorization
by
FDA.
prescribed
extensively
in
older
adult
patients
to
treat
coronavirus
disease
2019
(COVID-19)
infection.
In
this
study,
population
pharmacokinetic
modeling
with
clinical
study
data
was
employed
explore
profile
nirmatrelvir
Chinese
COVID-19
The
result
suggests
that
can
be
described
a
one-compartment
model
first-order
absorption
and
elimination
population.
calculated
apparent
clearance
(CL/F),
volumes
distribution
(V/F),
rate
constant
(ka)
for
typical
patient
were
4.16
L/h,
39.1
L,
0.776,
respectively.
area
under
curve
(AUC)
approximately
three-fold
higher
than
AUCs
Western
young
volunteers.
At
same
doses,
simulated
increased
26%,
43%,
72%,
135%
virtual
populations
creatinine
clearances
60,
45,
30,
15
mL/min,
Our
research
provides
instructive
reference
dose
selection
adults.
Scientific Reports,
Год журнала:
2025,
Номер
15(1)
Опубликована: Янв. 17, 2025
RP-HPLC
technique
was
developed
and
optimized
for
simultaneous
identification
estimation
of
nirmatrelvir
(NIR)
ritonavir
(RIT)
in
their
new
copackaged
tablet.
Stability
studied
after
exposure
to
different
five
stress
conditions;
alkali,
acid,
heat,
photo
oxidation
degradation.
The
chromatographic
separation
achieved
using
VDSpher
PUR
100
ODS
(4.6-mm
x
15-mm),
3.5
μm
column
mixture
0.03
M
potassium
di-hydrogen
phosphate
buffer
pH
4
acetonitrile
(45:55,
v/v)
as
mobile
phase.
temperature
set
at
40
°C,
flow
rate
1mL/min
UV
detection
215
nm.
NIR
RIT
retention
times
were
3.94
±
0.08
min
9.08
0.1
min,
respectively.
Linear
relationship
established
range
(1.5-105
µg/mL)
(1-70
with
good
reproducibility.
found
mean
percentage
recoveries
100.03%
99.85%,
method
shows
very
sensitivity
the
LOQ
LOD
be
3.001
&
0.990
µg/mL,
respectively
2.765
0.912
RIT.
approach
validated
concerning
ICH
guidelines
applied
successfully
dosage
from.
results
assay
proposed
compared
statistically
by
applying
published
one
agreement.
Therapeutic Drug Monitoring,
Год журнала:
2025,
Номер
unknown
Опубликована: Янв. 30, 2025
Nirmatrelvir/ritonavir
is
licensed
for
the
treatment
of
mild-to-moderate
coronavirus
disease
(COVID-19)
in
patients
at
an
increased
risk
progression
to
severe
disease.
However,
data
on
real-world
plasma
exposure
nirmatrelvir/ritonavir
remain
limited,
particularly
Chinese
patients.
This
study
aimed
assess
trough
concentration
(Ctrough)
and
identify
its
critical
factors
hospitalized
treated
with
300
mg/100
mg
twice
daily
over
a
5-day
course.
A
high-performance
liquid
chromatography-tandem
mass
spectrometry
assay
was
developed
validated
measure
Ctrough.
Correlation
analyses
were
performed
variables
influencing
Among
110
patients,
100%
had
concentrations
above
antiviral
vitro
90%
effective
concentration.
The
median
Ctrough
nirmatrelvir
4.55
mcg/mL
(15.6×
concentration),
ranging
from
0.65
12.44
mcg/mL.
Nirmatrelvir
normal
mild
renal
impairment
cohorts
comparable
(4.09
±
1.97
4.57
2.21
mcg/mL)
but
significantly
moderate
cohort
(6.41
2.31
mcg/mL).
Sex,
age,
obesity
not
associated
exposure.
high
COVID-19,
therapeutic
drug
monitoring
should
be
routinely
recommended,
except
impairment.